- Home
- EP vs TLSI Comparison
EP vs TLSI Comparison
Compare EP & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- TLSI
- Stock Information
- Founded
- EP 1983
- TLSI 2010
- Country
- EP United States
- TLSI United States
- Employees
- EP N/A
- TLSI N/A
- Industry
- EP Oil & Gas Production
- TLSI Medical Specialities
- Sector
- EP Energy
- TLSI Health Care
- Exchange
- EP Nasdaq
- TLSI Nasdaq
- Market Cap
- EP 248.9M
- TLSI 124.9M
- IPO Year
- EP N/A
- TLSI N/A
- Fundamental
- Price
- EP $6.51
- TLSI $4.69
- Analyst Decision
- EP
- TLSI Strong Buy
- Analyst Count
- EP 0
- TLSI 6
- Target Price
- EP N/A
- TLSI $11.75
- AVG Volume (30 Days)
- EP 31.6K
- TLSI 36.4K
- Earning Date
- EP 11-14-2024
- TLSI 11-14-2024
- Dividend Yield
- EP N/A
- TLSI N/A
- EPS Growth
- EP N/A
- TLSI N/A
- EPS
- EP N/A
- TLSI N/A
- Revenue
- EP $43,254,386.00
- TLSI $26,891,000.00
- Revenue This Year
- EP N/A
- TLSI $60.96
- Revenue Next Year
- EP N/A
- TLSI $53.65
- P/E Ratio
- EP N/A
- TLSI N/A
- Revenue Growth
- EP 10.97
- TLSI 67.90
- 52 Week Low
- EP $4.06
- TLSI $3.50
- 52 Week High
- EP $8.46
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- EP 44.48
- TLSI 51.68
- Support Level
- EP $6.43
- TLSI $4.72
- Resistance Level
- EP $8.12
- TLSI $5.32
- Average True Range (ATR)
- EP 0.38
- TLSI 0.31
- MACD
- EP -0.13
- TLSI 0.01
- Stochastic Oscillator
- EP 4.73
- TLSI 47.52
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.